Salt Palace

Qualtrics X4 Kicks Off in Salt Lake City

Retrieved on: 
Mercoledì, Maggio 1, 2024
Mayo Clinic, Backstreet Boys, State, AI, Ally Financial, TMT, Intelligence, Indiana University, Mass General Brigham, Enterprise, XM, Adidas, OpenAI, Salt Palace, NBA, Financial services, Stanford University Medical Center, Delta, DoorDash, Owens Corning, WorkJam, Porsche, Education, Certification, Book, Cisco, Driscoll's, Commercial software, Johnson & Johnson, Customer experience, Collection, American Express, Organization, Government, CX, Bain & Company, Health care, Shake Shack, Kickstarter, Growth, Fortune 500, Management

SALT LAKE  CITY, May 1, 2024 /PRNewswire/ -- QUALTRICS X4 -- Qualtrics, the leader and creator of the experience management category, today announced the official kickoff of X4®: The Experience Management Summit. The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City. The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.

Key Points: 
  • The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City.
  • The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.
  • "We have a fantastic line-up of visionary leaders who will inspire and prepare everyone at X4 to improve the experiences at their own organizations," said Qualtrics CEO Zig Serafin.
  • "X4 is a can't-miss event for executives, thought leaders and experience management professionals who are unlocking growth by creating emotional connections at scale with their customers and employees."

Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference

Retrieved on: 
Venerdì, Aprile 12, 2024
News, Conference, Therapy, Salt Palace, CCF

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced poster presentations on CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, at the Cholangiocarcinoma Foundation (CCF) 2024 Annual Conference to be held at the Salt Palace Convention Center in Salt Lake City, Utah from April 17–19, 2024.

Key Points: 
  • BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced poster presentations on CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, at the Cholangiocarcinoma Foundation (CCF) 2024 Annual Conference to be held at the Salt Palace Convention Center in Salt Lake City, Utah from April 17–19, 2024.
  • A copy of the presentation materials can be accessed on the News & Events section under “ Presentations ” of the Company’s website at www.compasstherapeutics.com once the presentation has concluded.

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Retrieved on: 
Mercoledì, Marzo 6, 2024
Neuropharmacology, Pharmacology, Algorithm, Microelectrode array, SOT, Artificial intelligence, Data management, Product management, Society of Toxicology, Salt Palace, Electrophysiology, Society, Organoid, Harvard Bioscience, Safety, Area studies, DSI, ChromeOS, HBIO, MEA, Machine learning, Research, Mesh, Environment, Online shopping

Complementing an already extensive product line, the new innovations provide exciting new opportunities for advancing preclinical and organoid-focused therapy development.

Key Points: 
  • Complementing an already extensive product line, the new innovations provide exciting new opportunities for advancing preclinical and organoid-focused therapy development.
  • The Company’s industry-leading GLP-compliant Ponemah™ preclinical data management platform now includes integrations with the new SoHo™ implantable telemetry solution and the VivaMARS™ high-capacity behavior monitoring system.
  • The integrated platform also opens new opportunities for the use of emerging machine learning-based algorithms to efficiently analyze large data pools.
  • The new Mesh MEA platform is designed for the emerging applications of organoids in research and discovery, safety pharmacology and toxicology.

BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting

Retrieved on: 
Lunedì, Novembre 13, 2023
Biotechnology, Technology, Health, Pharmaceutical, Oncology, Health Technology, Research, Artificial Intelligence, Genetics, Science, Clinical Trials, MSI, WES, TMB, American Securities, Salt Palace, Sequence, Epigenome-wide association study, Molecular diagnostics, Agilent Technologies, Journal, HRD, Chromosomal translocation, R, Molecular reference standards, AMP, Abstract (summary)

BostonGene , a leading provider of AI-driven molecular and immune profiling solutions today announced that an abstract has been accepted as a poster presentation for the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, which will be held November 14 - 18, 2023, at the Salt Palace Convention Center in Salt Lake City, UT.

Key Points: 
  • BostonGene , a leading provider of AI-driven molecular and immune profiling solutions today announced that an abstract has been accepted as a poster presentation for the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, which will be held November 14 - 18, 2023, at the Salt Palace Convention Center in Salt Lake City, UT.
  • During the event, BostonGene will also deliver a presentation at the AMP Corporate Workshop day and exhibit at booth 1301.
  • Details of BostonGene’s presence at AMP are below:
    Speaker: Katerina Nuzhdina, R&D, Head of Bioinformatics Pipelines Clinical Integration Division, BostonGene
    Tumor molecular characterization is key for advancing precision oncology.
  • In collaboration with Agilent, BostonGene will present its method for detecting somatic variants from cancer samples, enabling large-scale data analyses.

2023 BioUtah Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit

Retrieved on: 
Venerdì, Novembre 3, 2023
One Utah Center, Lake City, Doctor of Philosophy, Salt Palace, Salt Palace (arena), Representative, University, Education, Utah House of Representatives, Medical Innovation Bill, Telescopic sight

Salt Lake City, Utah--(Newsfile Corp. - November 3, 2023) - BioUtah today announced the winners of its 2023 Life Sciences Awards.

Key Points: 
  • Salt Lake City, Utah--(Newsfile Corp. - November 3, 2023) - BioUtah today announced the winners of its 2023 Life Sciences Awards.
  • Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City.
  • BioUtah's annual awards recognize leaders, innovators and entrepreneurs who have made significant contributions to the state's life sciences industry.
  • BioUtah will honor Daniel Simmons, PhD, president and chief scientist, Intronex Laboratories, with a Lifetime Achievement Award.

ChromaCode To Show New Data In Oncology and Blood Based Monitoring at the Association for Molecular Pathology 2023 Annual Meeting and Expo

Retrieved on: 
Martedì, Ottobre 31, 2023
Laboratory, Data analysis, NSCLC, Pathology, MPH, Medical laboratory, AMP, Nested polymerase chain reaction, University of Minnesota Medical School, MD, Corporation, Professor, Translational research, Turnaround time, Software, Development, Fellow, Genomics, Salt Palace, MRD, Blood, University, TAT, Cancer, Diagnosis, Management, Medical imaging

CARLSBAD, Calif., Oct. 31, 2023 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable solutions for laboratories, will present new data during a Corporate workshop and present two accepted scientific abstracts at the Association for Molecular Pathology (AMP) 2023 annual meeting, being held at the Salt Palace Convention Center in Salt Lake City, Utah, from November 14-18, 2023.

Key Points: 
  • "The ChromaCode team is proud to participate in this year's preeminent conference for molecular diagnostics, AMP 2023.
  • At the Corporate Workshop, we will be revealing new data showcasing the potential of HDPCR enabled multiplexing and ChromaCode software in transplant and minimal residual disease.
  • We look forward to engaging with fellow attendees at these presentations and at our Booth (1700)" stated Mark McDonough, Chief Executive Officer at ChromaCode.
  • Attendees can expect insights into the latest software tools, data analysis techniques, and their potential to enhance precision and accuracy in molecular testing.

BioUtah Announces Headline Speakers for the 2023 Mayer Brown Utah Life Sciences Summit

Retrieved on: 
Mercoledì, Ottobre 25, 2023
Summit, BD, Lake City, FDA, Myriad Genetics, Salt Palace, Telescopic sight

Salt Lake City, Utah--(Newsfile Corp. - October 25, 2023) - BioUtah, Utah's trade association serving the state's life sciences community, announced today an impressive line-up of speakers who will present at this year's 2023 Mayer Brown Utah Life Sciences Summit, November 9 at the Salt Palace Convention Center, in Salt Lake City.

Key Points: 
  • Salt Lake City, Utah--(Newsfile Corp. - October 25, 2023) - BioUtah, Utah's trade association serving the state's life sciences community, announced today an impressive line-up of speakers who will present at this year's 2023 Mayer Brown Utah Life Sciences Summit, November 9 at the Salt Palace Convention Center, in Salt Lake City.
  • BioUtah's Utah Life Sciences Summit presented by Mayer Brown is coming Nov. 9 to the Salt Palace Convention Center in Salt Lake City.
  • The Summit is Utah's premier life sciences event of the year, attracting record attendance.
  • Distinguished keynote speakers include: Joseph Smith, chief scientific officer, BD on medical device innovation.

Apple Hospitality REIT Acquires Courtyard by Marriott and Hyatt House in Downtown Salt Lake City and Announces Two Additional Hotels Under Contract for Purchase

Retrieved on: 
Giovedì, Ottobre 12, 2023
REIT, Lodging, Commercial Building & Real Estate, Construction & Property, Travel, STR, Walking, NYSE, Cottonwood Canyon, Acquisition, Investment, Tourism, Utah State Capitol, Real estate, Vivint Arena, Transport, Hyatt House, University, Temple Square, Salt Palace, Salt Lake City International Airport, Real estate mortgage investment conduit, Embassy Suites by Hilton, Hospitality, Courtyard, Hotel

“The acquisition of the Courtyard and the Hyatt House in downtown Salt Lake City expands our presence within the vibrant Salt Lake market, an area well known for its business-friendly environment, attractive cost of living, cultural attractions and proximity to outdoor recreational activities, which has seen significant economic growth in recent years and is poised for continued expansion.

Key Points: 
  • “The acquisition of the Courtyard and the Hyatt House in downtown Salt Lake City expands our presence within the vibrant Salt Lake market, an area well known for its business-friendly environment, attractive cost of living, cultural attractions and proximity to outdoor recreational activities, which has seen significant economic growth in recent years and is poised for continued expansion.
  • We are actively underwriting additional opportunities and are well positioned to further add to our portfolio in the coming months.”
    The Courtyard Salt Lake City Downtown is located at 345 West 100 South, Salt Lake City, Utah, and the Hyatt House Salt Lake City/Downtown is located at 140 South 300 West, Salt Lake City, Utah.
  • The Courtyard opened in October 2015 and the Hyatt House, which recently underwent a full soft-goods renovation, opened in January 2015.
  • Following the acquisition of the downtown Salt Lake City hotels, the Apple Hospitality hotel portfolio includes 222 hotels with 29,263 guest rooms geographically diversified throughout 37 states.

nRichDX to Exhibit at the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo

Retrieved on: 
Giovedì, Ottobre 12, 2023
Agilent Technologies, Cause of action, Professor, Urine, Plasma, Expo Hall, Innovation, CFRNA, Salt Palace, AMP, Research, CGAT, Chinese, Nucleic acid thermodynamics, Advanced technology, Liquid biopsy, MT, Dartmouth–Hitchcock Medical Center, Poster, Phosphorus

IRVINE, Calif., Oct. 12, 2023 /PRNewswire/ -- The Association for Molecular Pathology 2023 Annual Meeting & Expo will be held 14-18 November 2023 at the Salt Palace Convention Center in Salt Lake City, UT located in downtown Salt Lake City.

Key Points: 
  • Visit nRichDX® - maker of the Revolution Sample Prep System™ for liquid biopsy applications - in Booth #822 at AMP 2023.
  • Details at https://www.nrichdx.com/amp2023
    IRVINE, Calif., Oct. 12, 2023 /PRNewswire/ -- The Association for Molecular Pathology 2023 Annual Meeting & Expo will be held 14-18 November 2023 at the Salt Palace Convention Center in Salt Lake City, UT located in downtown Salt Lake City.
  • More information about AMP 2023, including specific exhibit hours and events is available at https://amp23.amp.org/.
  • For more information about nRichDX at AMP 2023, or to set an appointment to meet, visit https://www.nrichdx.com/amp2023 .

BioUtah's 2023 Utah Life Sciences Summit Presented by Mayer Brown Coming November 9 to Salt Lake City

Retrieved on: 
Mercoledì, Ottobre 4, 2023
FDA, GDP, Summit, Lake City, BD, Salt Palace, Telescopic sight

Salt Lake City, Utah--(Newsfile Corp. - October 4, 2023) - BioUtah, Utah's trade association dedicated to the life sciences community, today announced its 2023 Utah Life Sciences Summit presented by Mayer Brown.

Key Points: 
  • Salt Lake City, Utah--(Newsfile Corp. - October 4, 2023) - BioUtah, Utah's trade association dedicated to the life sciences community, today announced its 2023 Utah Life Sciences Summit presented by Mayer Brown.
  • The Summit will be held November 9 at the Salt Palace Convention Center in Salt Lake City.
  • BioUtah's Utah Life Sciences Summit presented by Mayer Brown is coming Nov. 9 to the Salt Palace Convention Center in Salt Lake City.
  • As one of the fastest growing life sciences hubs in the nation, Utah's industry directly and indirectly accounts for $22.6 billion in GDP and approximately 180,000 jobs.